Survey Among Healthcare Professionals Treating Patients With Metastatic Breast Cancer in Selected European Countries to Evaluate Their Knowledge on Management of Hyperglycemia When Using Alpelisib
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis Pharmaceuticals
Age
18–100
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Had prescribed Piqray to at least 1 locally advanced or MBC patient within 6 months prior to completing the survey.
Provided permission to share their anonymized responses in aggregate with EMA or NCAs, if requested.
You may not be if
HCPs who are direct employees of Novartis, the EMA (or any other regulatory bodies), or ICON.
Clareo Health | Survey Among Healthcare Professionals Treating Patients With Metastatic Breast Cancer in Selected European Countries to Evaluate Their Knowledge on Management of Hyperglycemia When Using Alpelisib
